Exploration du vécu psychologique et psychosocial chez des patients atteints d’un cancer de la prostate en France : analyses de deux études : VICAN et PRESAgE

Exploration du vécu psychologique et psychosocial chez des patients atteints d’un cancer de la prostate en France : analyses de deux études : VICAN et PRESAgE

Le cancer est désormais considéré comme une maladie chronique touchant une population toujours croissante. Une prise en charge et un suivi à long terme, à l’origine d’un bouleversement de la vie des patients et de leur entourage, semblent nécessaires et sont susceptibles d’initier une réorganisation...

Full description

Bibliographic Details
Main Author:	Girodet, Magali
Other Authors:	Lyon
Language:	fr
Published:	2019
Subjects:	Cancer Vécu Santé sexuelle Couple Qualité de vie Ajustement dyadique Prostate Surveillance active Experiences Sexual health Quality of life Coping Active surveillance 610
Online Access:	http://www.theses.fr/2019LYSE1270

Similar Items

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01)

Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance
by: Nuno Ramos, et al.
Published: (2020-12-01)

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
by: Ravi Kacker, et al.
Published: (2016-01-01)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
by: Salonee Shah, et al.
Published: (2021-05-01)

Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer—A population‐based cohort study
by: Rano Matta, et al.
Published: (2020-10-01)

Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate
by: Hagmann, S., et al.
Published: (2022)

Evaluation of various active surveillance protocols in prostate cancer
by: Kayhan Yılmaz, et al.
Published: (2014-06-01)

MRI and Active Surveillance for Prostate Cancer
by: Angelo Porreca, et al.
Published: (2020-08-01)

Changes in risk-group stratification of patients undergoing radical prostatectomy at the Southern Alberta Institute of Urology over time
by: Shiff B, et al.
Published: (2019-03-01)

Management and outcomes of Gleason six prostate cancer detected on needle biopsy: A single-surgeon experience over 6 years
by: Brayden March, et al.
Published: (2017-12-01)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
by: Matteo Ferro, et al.
Published: (2017-05-01)

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance
by: Roberta Mazzucchelli, et al.
Published: (2014-12-01)

Watchful Waiting Active Surveillance in Prostate Cancer Patients – a Population-Based Study Using the SEER-Medicare Linked Database
by: Kou, Tzuyung Doug
Published: (2008)

Computer Extracted Features from Initial H&E Tissue Biopsies Predict Disease Progression for Prostate Cancer Patients on Active Surveillance
by: Sacheth Chandramouli, et al.
Published: (2020-09-01)

Prostate volume effect on Gleason score upgrading in active surveillance appropriate patients
by: Emre Çamur, et al.
Published: (2019-07-01)

Current Progress and Controversies in Prostate Cancer Management
by: De-Xin Dong, et al.
Published: (2017-01-01)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
by: Agnieszka Latosinska, et al.
Published: (2018-08-01)

Psychosocial Correlates of Psychological Distress and Arousal in Prostate Cancer Survivors Undergoing Active Surveillance
by: Bustillo, Natalie Escobio
Published: (2011)

Analysis of different tumor volume thresholds of insignificant prostate cancer and their implications for active surveillance patient selection and monitoring
by: Dong Hoon Lee
Published: (2014-06-01)

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
by: Paolo Gandellini, et al.
Published: (2021-05-01)

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
by: Arnas Rakauskas, et al.
Published: (2021-07-01)

Modern Approach in Radiological Diagnosis of Prostate Cancer (Systematic Review of International Clinical Guidelines and Clinical Studies Over 2014–2020)
by: A. V. Vasilyev, et al.
Published: (2021-01-01)

Diagnostic du cancer de la prostate par imagerie moderne : place de l’IRM dans la sélection des candidats à une surveillance active et dans la caractérisation des zones tumorales intra-prostatiques
by: Ouzzane, Adil
Published: (2014)

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
by: Jinan Guo, et al.
Published: (2021-09-01)

A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
by: Samuel W. D. Merriel, et al.
Published: (2021-02-01)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
by: Subhabrata Mukherjee, et al.
Published: (2021-02-01)

THE LONG-TERM ONCOLOGICAL RESULTS OF RADICAL PROSTATECTOMY IN PATIENTS WITH A MAXIMUM FOLLOW-UP OF UP TO 15 YEARS, WHO MEET THE ERSPC (PRIAS) CRITERIA FOR ACTIVE SURVEILLANCE
by: E. I. Veliev, et al.
Published: (2014-07-01)

Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
by: Rasmus Nilsson, et al.
Published: (2021-03-01)

A Systematic Review of Artificial Intelligence in Prostate Cancer
by: Van Booven DJ, et al.
Published: (2021-01-01)

Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer
by: Yao-Lin Kao, et al.
Published: (2021-01-01)

The importance of PSA-Density in active surveillance for prostate cancer
by: Caner Ediz, et al.
Published: (2020-06-01)

THE LONG-TERM ONCOLOGICAL RESULTS OF RADICAL PROSTATECTOMY IN PATIENTS WITH A MAXIMUM FOLLOW-UP OF UP TO 15 YEARS, WHO MEET THE ERSPC (PRIAS) CRITERIA FOR ACTIVE SURVEILLANCE
by: E. I. Veliev, et al.
Published: (2014-07-01)

Observation versus treatment among men with favorable risk prostate cancer in a community-based integrated health care system: a retrospective cohort study
by: Furaha Kariburyo, et al.
Published: (2018-06-01)

MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer
by: Suraj Samtani, et al.
Published: (2021-08-01)

Active Surveillance in Prostate Cancer: Role of Available Biomarkers in Daily Practice
by: Belén Pastor-Navarro, et al.
Published: (2021-06-01)

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
by: Pietro Pepe, et al.
Published: (2016-12-01)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy
by: Sung Kyu Hong, et al.
Published: (2013-12-01)

Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance
by: Zambrano Norman, et al.
Published: (2014-04-01)

Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?
by: Marco Roscigno, et al.
Published: (2020-12-01)